Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · June 03, 2024

Effectiveness and Safety of Nabiximols in Patients With MS-Related Spasticity

Journal of Clinical Medicine


Additional Info

Disclosure statements are available on the authors' profiles:

Journal of Clinical Medicine
Effectiveness, Safety and Patients' Satisfaction of Nabiximols (Sativex®) on Multiple Sclerosis Spasticity and Related Symptoms in a Swiss Multicenter Study
J Clin Med 2024 May 14;[EPub Ahead of Print], R Sacco, GC Riccitelli, G Disanto, J Bogousslavsky, A Cavelti, D Czell, CP Kamm, U Kliesch, SP Ramseier, C Gobbi, C Zecca

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading